Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Dyadic International, Inc. (OTC: DYAI).

Full DD Report for DYAI

You must become a subscriber to view this report.


Recent News from (OTC: DYAI)

Dyadic International's (DYAI) CEO Mark Emalfarb on Q1 2018 Results - Earnings Call Transcript
Dyadic International, Inc. (DYAI) Q1 2018 Earnings Conference Call May 10, 2018 16:30 PM ET Executives Ping Rawson - Chief Accounting Officer Mark Emalfarb - Chief Executive Officer Analysts Richard Deutsch - National Securities Presentation Operator Good afternoon,...
Source: SeekingAlpha
Date: May, 13 2018 22:21
Dyadic International Reports First Quarter 2018 Financial Results
Three new research collaborations Positive results in our initial glycoengineering modifications of C1 strains Achieving high levels of productivity for therapeutic proteins Board approved a reverse stock split subject to shareholder approval Recognized industry thought leader...
Source: GlobeNewswire
Date: May, 10 2018 16:30
Dyadic International to Announce First Quarter 2018 Financial Results and Host Conference Call on Thursday May 10, 2018
JUPITER, Fla., April 25, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 expression system to help speed up the development and production of biologic vacci...
Source: GlobeNewswire
Date: April, 25 2018 16:30
Dyadic International's (DYAI) CEO Mark Emalfarb on Q4 2017 Results - Earnings Call Transcript
Dyadic International, Inc. (DYAI) Q4 2017 Earnings Conference Call March 27, 2018 05:00 PM ET Executives Ping Rawson - Chief Accounting Officer Mark Emalfarb - President and Chief Executive Officer Matthew Jones - Managing Director of Business Development and Licensing Analyst...
Source: SeekingAlpha
Date: March, 28 2018 15:35
Dyadic International Announces 2017 Year End Results and Recent Developments
$49.1 million of cash, cash equivalents and investment securities as of December 31, 2017 Successfully executed two funded collaborations in 2017 and signed three new collaborations in 2018 Early data generated from our research programs are showing encouraging results for C1 techn...
Source: GlobeNewswire
Date: March, 27 2018 16:30
Dyadic International Appoints Chief Accounting Officer
JUPITER, Fla., March 15, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), today announced that Chief Financial Officer Thomas L. Dubinski
 will be on a medical leave of absence, effectively immediately. In Mr. Dubinski’s absence, ...
Source: GlobeNewswire
Date: March, 15 2018 16:30
Dyadic International to Announce Year End 2017 Financial Results and Host Conference Call on Tuesday March 27, 2018
JUPITER, Fla., March 13, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 expression system to help speed up the development and production of biologic vacci...
Source: GlobeNewswire
Date: March, 13 2018 16:30
VIDEO: Dyadic International Inc., President, Chief Executive Officer and Director Mark A. Emalfarb and Chief Commercial Officer Matthew Jones Featured in OTCQX Video Series
NEW YORK , March 6, 2018 /PRNewswire/ --   Dyadic International, Inc. (OTCQX: DYAI) President, CEO and Director Mark A. Emalfarb , and Chief Commercial Officer Matthew S. Jones , were interviewed by OTC Markets Group (OTCQX: OTCM) in its prominent OTCQX® Video Series. T...
Source: PR Newswire
Date: March, 06 2018 10:00
The Story Behind Growth: New Report Discusses Harleysville Savings Financial and Dyadic International - Emerging Trends Within New Industry
NEW YORK, NY / ACCESSWIRE / March 5 , 2018 / Latest key findings by Growth Market Report for all traders, shareholders, and investors of Harleysville Savings Financial Corp. (OTCQX: HARL) and Dyadic International Inc. (OTCQX: DYAI), including recent technical analysis and consolidated fun...
Source: ACCESSWIRE IA
Date: March, 05 2018 07:30
Dyadic International, Inc. Announces Research and Development Collaboration with Mitsubishi Tanabe Pharma Corporation To Produce Two Target Proteins in C1
JUPITER, Fla., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to speed up the development and production of biologic prod...
Source: GlobeNewswire
Date: February, 27 2018 08:30

 


About Dyadic International, Inc. (OTC: DYAI)

Logo for Dyadic International, Inc. (OTC: DYAI)

Dyadic International, Inc. is a global biotechnology company focused on further improving and applying the proprietary C expression system to help drug developers and manufacturers bring biologic drugs to market faster, in greater volumes, at lower cost, and with new properties that will improve access and cost to patients and the healthcare system, but most importantly save lives.

 

Contact Information

 

 

Current Management

  • Mark Emalfarb / CEO, President
  • Thomas L. Dubinski / CFO
  • Ping Rawson / Director, Financial Reporting
  • Hiedi Zosiak / Executive Assistant
  • Michael P. Tarnok / Chairman, Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
  • Arindam Bose / Independent Director, Audit Committee Member, Nominating Committee Member
    • Mr. Bose has served as a member of the Board since March . Mr. Bose brings over sixteen years of experience in capital raising, private equity, wealth management and client relationship management. He cofounded Velocitas Partners in and is also the General Manager of Al Etihad Financial Advisors, UAE, an Emirates Securities and Commodities Authority licensed financial advisory firm, where he has worked since January . From April to December , Mr. Bose was a Partner at Al Masah Capital Limited. From January to March , Mr. Bose was a Director in the Global Banking and Markets Group at Royal Bank of Scotland, UK. His previous roles have included International Private banking at Coutts amp Company, UK, The National Investor, Abu Dhabi, UAE from April to December and on a joint venture between Government of Dubai amp the World Bank Group where he worked as an Associate Technology amp Security from November to March . Mr. Bose is a member of the Board of Directors of AB Holdings and General Stores and Engineering Company Private Ltd. He completed his executive training at Manchester University and received his Bachelors in Engineering from Barkatullah Vishwavidyalaya, University of Bhopal, Madhya Pradesh India. Mr. Bose is an appointee of Velocitas Partners pursuant to the terms of a Voting Agreement, dated February , and effective on March , .
  • Mark Emalfarb /
  • Seth Herbst / Independent Director, Compensation Committee Member, Nominating Committee Member
  • Jack Kaye / Independent Director, Audit Committee Member, Compensation Committee Member

Current Share Structure

  • Market Cap: $56,263,948 - 03/09/2018
  • Authorized: 100,000,000 - 03/09/2018
  • Issue and Outstanding: 38,936,988 - 03/09/2018
  • Float: 20,478,195 - 09/30/2017

 


Recent Filings from (OTC: DYAI)

Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 12 2018
Quarterly Report - Q3 2017 Issuer's Quarterly Report
Filing Type: Quarterly Report - Q3 2017 Issuer's Quarterly ReportFiling Source: OTC Markets
Filing Date: November, 09 2017
Supplemental Information - Dyadic Announces $5M Stock Repurchase Program
Filing Type: Supplemental Information - Dyadic Announces $5M Stock Repurchase ProgramFiling Source: OTC Markets
Filing Date: August, 16 2017
Quarterly Report - Q2 2017 Issuer's Quarterly Report
Filing Type: Quarterly Report - Q2 2017 Issuer's Quarterly ReportFiling Source: OTC Markets
Filing Date: August, 10 2017
Supplemental Information - Dyadic Hosts Annual Meeting of Shareholders
Filing Type: Supplemental Information - Dyadic Hosts Annual Meeting of ShareholdersFiling Source: OTC Markets
Filing Date: June, 07 2017
Officer/Director/Affiliate Stock Transactions - Dyadic Announces Board Members Share Purchase
Filing Type: Officer/Director/Affiliate Stock Transactions - Dyadic Announces Board Members Share PurchaseFiling Source: OTC Markets
Filing Date: May, 25 2017
Quarterly Report - Q1 2017 Issuer's Quarterly Report
Filing Type: Quarterly Report - Q1 2017 Issuer's Quarterly ReportFiling Source: OTC Markets
Filing Date: May, 11 2017
Proxy Statement - 2017 Annual Meeting Notice and Proxy Statement
Filing Type: Proxy Statement - 2017 Annual Meeting Notice and Proxy StatementFiling Source: OTC Markets
Filing Date: April, 12 2017
Annual Report - 2016 Annual Report and Consolidated Financial Statements (Amended Audit Report)
Filing Type: Annual Report - 2016 Annual Report and Consolidated Financial Statements (Amended Audit Report)Filing Source: OTC Markets
Filing Date: March, 24 2017
Supplemental Information - Exhibit 1.2 - Amended and Restated Bylaws
Filing Type: Supplemental Information - Exhibit 1.2 - Amended and Restated BylawsFiling Source: OTC Markets
Filing Date: March, 15 2017

 

 


Daily Technical Chart for (OTC: DYAI)

Daily Technical Chart for (OTC: DYAI)


Stay tuned for daily updates and more on (OTC: DYAI)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: DYAI)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

Monsta Trader
@MonstaTrader

 

 


Disclaimer: Monsta Trader publishes reports providing information on selected companies. Monsta Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. Monsta Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in DYAI is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Monsta Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. Monsta Trader does not own any shares of DYAI and does not buy, sell, or trade any shares of DYAI. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by Monsta Trader. All rights reserved. Our Full Disclaimer: http://monstatrader.com/disclaimer/